Gemcitabine-erlotinib regimen
Jump to navigation
Jump to search
| Gemcitabine-erlotinib regimen | |
|---|---|
| Term | Gemcitabine-erlotinib regimen |
| Short definition | gemcitabine-cisplatin regimen (jem-SY-tuh-been-sis-PLA-tin REH-jih-men) A chemotherapy combination used to treat malignant mesothelioma, advanced non-small cell lung cancer , advanced bladder cancer, advanced cervical cancer, pancreatic cancer and epithelial ovarian cancer. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
gemcitabine-erlotinib regimen - (pronounced) (jem-SY-tuh-been-er-LOH-tih-nib REH-jih-men) A chemotherapy combination used to treat locally advanced and metastatic pancreatic cancer. It includes the active ingredients gemcitabine hydrochloride and erlotinib hydrochloride. Also called Gemcitabine-Tarceva regimen
External links
- Medical encyclopedia article on Gemcitabine-erlotinib regimen
- Wikipedia's article - Gemcitabine-erlotinib regimen
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski